BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31454064)

  • 1. Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study.
    Kang J; Chang Y; Ahn J; Oh S; Koo DH; Lee YG; Shin H; Ryu S
    Int J Cancer; 2019 Dec; 145(12):3267-3275. PubMed ID: 31454064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
    Koh CH; Bhoo-Pathy N; Ng KL; Jabir RS; Tan GH; See MH; Jamaris S; Taib NA
    Br J Cancer; 2015 Jun; 113(1):150-8. PubMed ID: 26022929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
    Grilz E; Posch F; Königsbrügge O; Schwarzinger I; Lang IM; Marosi C; Pabinger I; Ay C
    Thromb Haemost; 2018 Nov; 118(11):1875-1884. PubMed ID: 30296815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
    Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
    Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Neutrophil-Lymphocyte Ratio in Cardiogenic Shock: A Cohort Study.
    Peng Y; Wang J; Xiang H; Weng Y; Rong F; Xue Y; Ji K
    Med Sci Monit; 2020 May; 26():e922167. PubMed ID: 32418983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH
    Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study.
    Fest J; Ruiter TR; Groot Koerkamp B; Rizopoulos D; Ikram MA; van Eijck CHJ; Stricker BH
    Eur J Epidemiol; 2019 May; 34(5):463-470. PubMed ID: 30569368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer.
    Bar-Ad V; Palmer J; Li L; Lai Y; Lu B; Myers RE; Ye Z; Axelrod R; Johnson JM; Werner-Wasik M; Cowan SW; Evans NR; Hehn BT; Solomides CC; Wang C
    Clin Transl Oncol; 2017 Jun; 19(6):711-717. PubMed ID: 27909873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.
    Liu D; Huang Y; Li L; Song J; Zhang L; Li W
    BMC Cancer; 2017 Dec; 17(1):882. PubMed ID: 29268698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neutrophil-lymphocyte ratio: A promising predictor of mortality in coronary care unit patients - A cohort study.
    Sun H; Que J; Peng Y; Ye H; Xiang H; Han Y; Wang J; Ji K
    Int Immunopharmacol; 2019 Sep; 74():105692. PubMed ID: 31228818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study.
    Chen G; Che L; Lai M; Wei T; Chen C; Zhu P; Ran J
    BMC Endocr Disord; 2024 May; 24(1):64. PubMed ID: 38730476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
    Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y
    PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?
    Unal D; Eroglu C; Kurtul N; Oguz A; Tasdemir A
    Asian Pac J Cancer Prev; 2013; 14(9):5237-42. PubMed ID: 24175807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.